Global Primary Biliary Cholangitis Treatment Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Primary Biliary Cholangitis Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Ursodeoxycholic Acid (UDCA)
1.2.3 Obeticholic Acid (Ocaliva)
1.3 Market by Application
1.3.1 Global Primary Biliary Cholangitis Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Primary Biliary Cholangitis Treatment Market Perspective (2020-2031)
2.2 Global Primary Biliary Cholangitis Treatment Growth Trends by Region
2.2.1 Global Primary Biliary Cholangitis Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Primary Biliary Cholangitis Treatment Historic Market Size by Region (2020-2025)
2.2.3 Primary Biliary Cholangitis Treatment Forecasted Market Size by Region (2026-2031)
2.3 Primary Biliary Cholangitis Treatment Market Dynamics
2.3.1 Primary Biliary Cholangitis Treatment Industry Trends
2.3.2 Primary Biliary Cholangitis Treatment Market Drivers
2.3.3 Primary Biliary Cholangitis Treatment Market Challenges
2.3.4 Primary Biliary Cholangitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Primary Biliary Cholangitis Treatment Players by Revenue
3.1.1 Global Top Primary Biliary Cholangitis Treatment Players by Revenue (2020-2025)
3.1.2 Global Primary Biliary Cholangitis Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Primary Biliary Cholangitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Primary Biliary Cholangitis Treatment Revenue
3.4 Global Primary Biliary Cholangitis Treatment Market Concentration Ratio
3.4.1 Global Primary Biliary Cholangitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Primary Biliary Cholangitis Treatment Revenue in 2024
3.5 Global Key Players of Primary Biliary Cholangitis Treatment Head office and Area Served
3.6 Global Key Players of Primary Biliary Cholangitis Treatment, Product and Application
3.7 Global Key Players of Primary Biliary Cholangitis Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Primary Biliary Cholangitis Treatment Breakdown Data by Type
4.1 Global Primary Biliary Cholangitis Treatment Historic Market Size by Type (2020-2025)
4.2 Global Primary Biliary Cholangitis Treatment Forecasted Market Size by Type (2026-2031)
5 Primary Biliary Cholangitis Treatment Breakdown Data by Application
5.1 Global Primary Biliary Cholangitis Treatment Historic Market Size by Application (2020-2025)
5.2 Global Primary Biliary Cholangitis Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Primary Biliary Cholangitis Treatment Market Size (2020-2031)
6.2 North America Primary Biliary Cholangitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025)
6.4 North America Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Primary Biliary Cholangitis Treatment Market Size (2020-2031)
7.2 Europe Primary Biliary Cholangitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025)
7.4 Europe Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Primary Biliary Cholangitis Treatment Market Size (2020-2031)
8.2 Asia-Pacific Primary Biliary Cholangitis Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Primary Biliary Cholangitis Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Primary Biliary Cholangitis Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Primary Biliary Cholangitis Treatment Market Size (2020-2031)
9.2 Latin America Primary Biliary Cholangitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025)
9.4 Latin America Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Primary Biliary Cholangitis Treatment Market Size (2020-2031)
10.2 Middle East & Africa Primary Biliary Cholangitis Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Primary Biliary Cholangitis Treatment Introduction
11.1.4 Novartis Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.1.5 Novartis Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Introduction
11.2.4 Bristol-Myers Squibb Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Primary Biliary Cholangitis Treatment Introduction
11.3.4 Pfizer Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Primary Biliary Cholangitis Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.4.5 GlaxoSmithKline Recent Development
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Company Details
11.5.2 Teva Pharmaceutical Business Overview
11.5.3 Teva Pharmaceutical Primary Biliary Cholangitis Treatment Introduction
11.5.4 Teva Pharmaceutical Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.5.5 Teva Pharmaceutical Recent Development
11.6 Retrophin
11.6.1 Retrophin Company Details
11.6.2 Retrophin Business Overview
11.6.3 Retrophin Primary Biliary Cholangitis Treatment Introduction
11.6.4 Retrophin Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.6.5 Retrophin Recent Development
11.7 Lumena Pharmaceuticals
11.7.1 Lumena Pharmaceuticals Company Details
11.7.2 Lumena Pharmaceuticals Business Overview
11.7.3 Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Introduction
11.7.4 Lumena Pharmaceuticals Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.7.5 Lumena Pharmaceuticals Recent Development
11.8 Intercept Pharmaceuticals
11.8.1 Intercept Pharmaceuticals Company Details
11.8.2 Intercept Pharmaceuticals Business Overview
11.8.3 Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Introduction
11.8.4 Intercept Pharmaceuticals Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025)
11.8.5 Intercept Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Primary Biliary Cholangitis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ursodeoxycholic Acid (UDCA)
Table 3. Key Players of Obeticholic Acid (Ocaliva)
Table 4. Global Primary Biliary Cholangitis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Primary Biliary Cholangitis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Primary Biliary Cholangitis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Primary Biliary Cholangitis Treatment Market Share by Region (2020-2025)
Table 8. Global Primary Biliary Cholangitis Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Primary Biliary Cholangitis Treatment Market Share by Region (2026-2031)
Table 10. Primary Biliary Cholangitis Treatment Market Trends
Table 11. Primary Biliary Cholangitis Treatment Market Drivers
Table 12. Primary Biliary Cholangitis Treatment Market Challenges
Table 13. Primary Biliary Cholangitis Treatment Market Restraints
Table 14. Global Primary Biliary Cholangitis Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Primary Biliary Cholangitis Treatment Market Share by Players (2020-2025)
Table 16. Global Top Primary Biliary Cholangitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Biliary Cholangitis Treatment as of 2024)
Table 17. Ranking of Global Top Primary Biliary Cholangitis Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Primary Biliary Cholangitis Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Primary Biliary Cholangitis Treatment, Headquarters and Area Served
Table 20. Global Key Players of Primary Biliary Cholangitis Treatment, Product and Application
Table 21. Global Key Players of Primary Biliary Cholangitis Treatment, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Primary Biliary Cholangitis Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Primary Biliary Cholangitis Treatment Revenue Market Share by Type (2020-2025)
Table 25. Global Primary Biliary Cholangitis Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Primary Biliary Cholangitis Treatment Revenue Market Share by Type (2026-2031)
Table 27. Global Primary Biliary Cholangitis Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Primary Biliary Cholangitis Treatment Revenue Market Share by Application (2020-2025)
Table 29. Global Primary Biliary Cholangitis Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Primary Biliary Cholangitis Treatment Revenue Market Share by Application (2026-2031)
Table 31. North America Primary Biliary Cholangitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Primary Biliary Cholangitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Primary Biliary Cholangitis Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Primary Biliary Cholangitis Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Primary Biliary Cholangitis Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Primary Biliary Cholangitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Primary Biliary Cholangitis Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Primary Biliary Cholangitis Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Primary Biliary Cholangitis Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 46. Novartis Company Details
Table 47. Novartis Business Overview
Table 48. Novartis Primary Biliary Cholangitis Treatment Product
Table 49. Novartis Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Bristol-Myers Squibb Company Details
Table 52. Bristol-Myers Squibb Business Overview
Table 53. Bristol-Myers Squibb Primary Biliary Cholangitis Treatment Product
Table 54. Bristol-Myers Squibb Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 55. Bristol-Myers Squibb Recent Development
Table 56. Pfizer Company Details
Table 57. Pfizer Business Overview
Table 58. Pfizer Primary Biliary Cholangitis Treatment Product
Table 59. Pfizer Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Primary Biliary Cholangitis Treatment Product
Table 64. GlaxoSmithKline Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Teva Pharmaceutical Company Details
Table 67. Teva Pharmaceutical Business Overview
Table 68. Teva Pharmaceutical Primary Biliary Cholangitis Treatment Product
Table 69. Teva Pharmaceutical Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 70. Teva Pharmaceutical Recent Development
Table 71. Retrophin Company Details
Table 72. Retrophin Business Overview
Table 73. Retrophin Primary Biliary Cholangitis Treatment Product
Table 74. Retrophin Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 75. Retrophin Recent Development
Table 76. Lumena Pharmaceuticals Company Details
Table 77. Lumena Pharmaceuticals Business Overview
Table 78. Lumena Pharmaceuticals Primary Biliary Cholangitis Treatment Product
Table 79. Lumena Pharmaceuticals Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 80. Lumena Pharmaceuticals Recent Development
Table 81. Intercept Pharmaceuticals Company Details
Table 82. Intercept Pharmaceuticals Business Overview
Table 83. Intercept Pharmaceuticals Primary Biliary Cholangitis Treatment Product
Table 84. Intercept Pharmaceuticals Revenue in Primary Biliary Cholangitis Treatment Business (2020-2025) & (US$ Million)
Table 85. Intercept Pharmaceuticals Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report


List of Figures
Figure 1. Primary Biliary Cholangitis Treatment Picture
Figure 2. Global Primary Biliary Cholangitis Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Primary Biliary Cholangitis Treatment Market Share by Type: 2024 VS 2031
Figure 4. Ursodeoxycholic Acid (UDCA) Features
Figure 5. Obeticholic Acid (Ocaliva) Features
Figure 6. Global Primary Biliary Cholangitis Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Primary Biliary Cholangitis Treatment Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Primary Biliary Cholangitis Treatment Report Years Considered
Figure 12. Global Primary Biliary Cholangitis Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Primary Biliary Cholangitis Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Primary Biliary Cholangitis Treatment Market Share by Region: 2024 VS 2031
Figure 15. Global Primary Biliary Cholangitis Treatment Market Share by Players in 2024
Figure 16. Global Top Primary Biliary Cholangitis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Biliary Cholangitis Treatment as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Primary Biliary Cholangitis Treatment Revenue in 2024
Figure 18. North America Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Primary Biliary Cholangitis Treatment Market Share by Country (2020-2031)
Figure 20. United States Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Primary Biliary Cholangitis Treatment Market Share by Country (2020-2031)
Figure 24. Germany Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Primary Biliary Cholangitis Treatment Market Share by Region (2020-2031)
Figure 32. China Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Primary Biliary Cholangitis Treatment Market Share by Country (2020-2031)
Figure 40. Mexico Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Primary Biliary Cholangitis Treatment Market Share by Country (2020-2031)
Figure 44. Turkey Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Primary Biliary Cholangitis Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Novartis Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 49. Pfizer Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 51. Teva Pharmaceutical Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 52. Retrophin Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 53. Lumena Pharmaceuticals Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 54. Intercept Pharmaceuticals Revenue Growth Rate in Primary Biliary Cholangitis Treatment Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit